Vitamin D Receptor Agonists Target CXCL10: New Therapeutic Tools for Resolution of Inflammation
Open Access
- 17 April 2013
- journal article
- review article
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-11
Abstract
Understanding the many biological extraskeletal actions of vitamin D has increased in the past decades. Indeed, vitamin D and analogue molecules, besides the classical actions on bone metabolism, exert several beneficial effects on metabolic homeostasis, heart-cardiovascular, brain, and muscle physiological functions, throughout the interaction with the specific vitamin D receptor (VDR). In particular, VDR agonists powerfully control innate and adaptive immune system with favorable effects on human health. VDR ligands act as immunomodulators that are potent enough to retain anti-inflammatory effects, even though the mechanism underlying those effects is not yet fully elucidated. VDR agonists exert a significant suppression of inflammatory processes switching the immune response from T helper 1 (Th1) to T helper 2 (Th2) dominance and counteracting the self-enhancing inflammatory loop between immune and resident cells, especially by cytokine release impairment. Those molecules are able, indeed, to reduce the release of the interferon (IFN)-induced 10 kDa protein IP-10/CXCL10, a powerful chemokine driving Th1-mediated inflammation. Based on their features, VDR ligands show the potentiality to be included in immunosuppressive regimens, aimed to control auto- and alloimmune Th1-driven overreactivity, occurring, for example, in autoimmune disease or graft rejection.Keywords
This publication has 127 references indexed in Scilit:
- The Vitamin D Receptor: New Paradigms for the Regulation of Gene Expression by 1,25-Dihydroxyvitamin D3Endocrinology and Metabolism Clinics of North America, 2010
- 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3The Journal of Immunology, 2009
- Phenotypic and functional markers for 1α,25-dihydroxyvitamin D3-modified regulatory dendritic cellsClinical and Experimental Immunology, 2009
- Ligation of TLR9 induced on human IL-10–secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory functionJournal of Clinical Investigation, 2009
- Vitamin effects on the immune system: vitamins A and D take centre stageNature Reviews Immunology, 2008
- Immunosuppression in cardiac graft rejection: A human in vitro model to study the potential use of new immunomodulatory drugsExperimental Cell Research, 2008
- Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytesJournal of Endocrinology, 2007
- The Role of the Vitamin D Endocrine System in Health and DiseaseNew England Journal of Medicine, 1989
- γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophagesBiochemical and Biophysical Research Communications, 1985
- 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.Journal of Clinical Investigation, 1984